跳至主要内容
临床试验/NL-OMON45744
NL-OMON45744撤回不适用

Pharmacokinetics of midazolam in the elderly on the Intensive Care Unit: a pilot study - MIKIEL - pilot

Intensive Care0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >70 years ;
  • Admitted to the ICU and institution of invasive mechanical ventilation
  • Intravenously administration of midazolam;
  • Expected midazolam administration for at least 12 hours;

排除标准

  • Use of CYP3A4 inhibitors or inductors at the start of the study;
  • o Strong to very strong CYP3A4 inhibitors: boceprevir, clarithromycin, erythromycin, grapefruit juice, indinavir, itraconazole, ketoconazole, posaconazole, ritonavir, saquinavir, telaprevir, telithromycin and voriconazole.
  • o Strong to very strong CYP3A4 inductors: carbamazepine, dabrafenib, rifampicin and Saint John`s-wort.
  • Patients participating in another study;
  • Prescription of other sedatives (except fentanyl);
  • Patients suffering from cerebral condition, that may influence RASS scores.

研究者

发起方
Intensive Care

相似试验

Pharmacokinetics of midazolam in the elderly on the... | 临床试验